• Current through October 23, 2012

Before prescribing, administering, or furnishing a prescription medication for an off-label use, a prescriber shall make every reasonable effort to:

(1) Explain to the patient, in easily understood terms, that the medication is not within the uses approved for that medication by the FDA; and

(2) Provide the patient with information regarding the potential risks and side effects associated with using the medication for the off-label use.

(Mar. 26, 2008, D.C. Law 17-131, § 203, 55 DCR 1659.)

HISTORICAL AND STATUTORY NOTES

Legislative History of Laws

For Law 17-131, see notes following § 48-841.01.